Methylphenidate disrupts social play behavior in adolescent rats (Neuropsychopharmacology (2008) 33 (2946-2956) DOI: 10.1038/npp.2008.10);Methylphenidate disrupts social play behavior in adolescent rats

Neuropsychopharmacology

Volumn 33, Issue 12, 2008, Pages 2946-2956

  Vanderschuren, Louk J M J ^a,b   Trezza, Viviana ^a   Griffioen Roose, Sanne ^a   Schiepers, Olga J G ^b   Van Leeuwen, Natascha ^a   De Vries, Taco J ^b   Schoffelmeer, Anton N M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adolescent; Atomoxetine; Behavioral inhibition; Methylphenidate; Social behavior; 2 adrenoceptor

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 1 ADRENERGIC RECEPTOR; APOMORPHINE; ATOMOXETINE; BETA ADRENERGIC RECEPTOR; DOPAMINE RECEPTOR; FLUPENTIXOL; METHYLPHENIDATE; NORADRENALIN; PRAZOSIN; PROPRANOLOL; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION DEFICIT DISORDER; COGNITIVE DEVELOPMENT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; INHIBITION (PSYCHOLOGY); LOW DRUG DOSE; MALE; NONHUMAN; PLAY; PRIORITY JOURNAL; RAT; SOCIAL BEHAVIOR;

EID: 53949120046     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.65     Document Type: Erratum

References (94)

1. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, IV-TR edn. American Psychiatric Association: Washington, DC.
2. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon Jr WA (2002). Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5: 13-14.
3. Arakawa O (1994). Effects of methamphetamine and methylphenidate on single and paired rat open-field behaviors. Physiol Behav 55: 441-446.
4. Arnsten AFT (2006). Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 31: 2376-2383.
5. Arnsten AFT, Dudley AG (2005). Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav Brain Funct 1: 2.
6. Aron AR, Dowson JH, Sahakian BJ, Robbins TW (2003). Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 54: 1465-1468.
7. Aron AR, Robbins TW, Poldrack RA (2004). Inhibition and the right inferior frontal cortex. Trends Cogn Sci 8: 170-177.
8. Aston-Jones G, Cohen JD (2005). An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 28: 403-450.
9. Baldo BA, Kelley AE (2007). Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology 191: 439-459.
10. Barbano MF, Cador M (2007). Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology 191: 497-506.
11. Beatty WW, Costello KB, Berry SL (1984). Suppression of play fighting by amphetamine: effects of catecholamine antagonists, agonists and synthesis inhibitors. Pharmacol Biochem Behav 20: 747-755.
12. Beatty WW, Dodge AM, Dodge LJ, Panksepp J (1982). Psychomotor stimulants, social deprivation and play in juvenile rats. Pharmacol Biochem Behav 16: 417-422.
13. Benet LZ, Kroetz DL, Sheiner LB (1996). The dynamics of drug absorption, distribution, and elimination. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill: New York. pp 3-27.
14. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AFT, Kelley AE, Schmeichel B et al (2006). Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60: 1111-1120.
15. Berridge KC (2007). The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology 191: 391-431.
16. Biederman J, Faraone SV (2005). Attention-deficit hyperactivity disorder. Lancet 366: 237-248.
17. Biederman J, Spencer T (1999). Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46: 1234-1242.
18. Bizot J-C, Chenault N, Houzé B, Herpin A, David S, Pothion S et al (2007). Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats. Psychopharmacology 193: 215-223.
19. Bolaños CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ (2003). Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54: 1317-1329.
20. Brandon CL, Marinelli M, Baker LK, White FJ (2001). Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25: 651-661.
21. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH et al (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27: 699-711.
22. Calcagnetti DJ, Schechter MD (1992). Place conditioning reveals the rewarding aspect of social interaction in juvenile rats. Physiol Behav 51: 667-672.
23. Cardinal RN, Parkinson JA, Hall J, Everitt BJ (2002). Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26: 321-352.
24. Carlezon Jr WA, Konradi C (2004). Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology 47(Suppl 1): 47-60.
25. Chacko A, Pelham WE, Gnagy EM, Greiner A, Vallano G, Bukstein O et al (2005). Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 44: 249-257.
26. Chamberlain SR, Müller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2006). Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311: 861-863.
27. Connor DF, Glatt SJ, Lopez ID, Jackson D, Melloni Jr RH (2002). Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry 41: 253-261.
28. Crowder WF, Hutto Jr CW (1992). Operant place conditioning measures examined using two nondrug reinforcers. Pharmacol Biochem Behav 41: 817-824.
29. Dews PB (1958). Studies on behavior. IV. Stimulant actions of methamphetamine. J Pharmacol Exp Ther 122: 137-147.
30. Eagle DM, Tufft MRA, Goodchild HL, Robbins TW (2007). Differential effects of modafinil and methylphenidate on stopsignal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology 192: 193-206.
31. Elia J, Ambrosini PJ, Rapoport JL (1999). Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 340: 780-788.
32. Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW (1997). Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131: 196-206.
33. 3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus. J Pharmacol Exp Ther 210: 422-428.
34. Fone KCF, Nutt DJ (2005). Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol 5: 87-93.
35. Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D et al (2000). Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther 295: 51-57.
36. Hawk Jr LW, Yartz AR, Pelham Jr WE, Lock TM (2003). The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder. Psychopharmacology 165: 118-127.
37. Hinshaw SP, Lee SS (2000). Ritalin effects on aggression and antisocial behavior. In: Greenhill LL, Osman BB (eds). Ritalin: Theory and Practice. Mary Ann Liebert Inc. Publishers: New Rochelle. pp 237-251.
38. Hol T, Van den Berg C, Van Ree JM, Spruijt BM (1999). Isolation during the play period in infancy decreases adult social interactions in rats. Behav Brain Res 100: 91-97.
39. Humphreys AP, Einon DF (1981). Play as a reinforcer for maze-learning in juvenile rats. Anim Behav 29: 259-270.
40. Kratochvil CJ, Wilens TE, Greenhill LL, Gao H, Baker KD, Feldman PD et al (2006). Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45: 919-927.
41. Kuczenski R, Segal DS (2002). Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22: 7264-7271.
42. Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J et al (2004). International consensus statement on attention-deficit/ hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol 14: 11-28.
43. Lyon M, Robbins TW (1975). The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In: Essman W, Valzelli L (eds). Current Developments in Psychopharmacology. Spectrum: New York. pp 79-163.
44. Mehta MA, Goodyer IM, Sahakian BJ (2004). Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry 45: 293-305.
45. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW (2000). Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20: RC65 (1-6).
46. Michelson DM, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ et al (2003). Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53: 112-120.
47. Miczek KA, Haney M, Tidey J, Vatne T, Weerts E, DeBold JF (1989). Temporal and sequential patterns of agonistic behavior: effects of alcohol, anxiolytics and psychomotor stimulants. Psychopharmacology 97: 149-151.
48. Moro M, Salvador A, Simón VM (1997). Changes in the structure of the agonistic behavior of mice produced by D-amphetamine. Pharmacol Biochem Behav 56: 47-54.
49. Niesink RJM, Van Ree JM (1989). Involvement of opioid and dopaminergic systems in isolation-induced pinning and social grooming of young rats. Neuropharmacology 28: 411-418.
50. Normansell L, Panksepp J (1990). Effects of morphine and naloxone on play-rewarded spatial discrimination in juvenile rats. Dev Psychobiol 23: 75-83.
51. Overtoom CCE, Verbaten MN, Kemner C, Kenemans JL, Van Engeland H, Buitelaar JK et al (2003). Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with attention deficit hyperactivity disorder. Behav Brain Res 145: 7-15.
52. Panksepp J, Siviy SM, Normansell L (1984). The psychobiology of play: theoretical and methodological perspectives. Neurosci Biobehav Rev 8: 465-492.
53. Pelham Jr WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM et al (2001). Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107: e105.
54. Pellis SM (1988). Agonistic versus amicable targets of attack and defense: consequences for the origin, function and descriptive classification of play-fighting. Aggress Behav 14: 85-104.
55. Pellis SM, Pellis VC (1987). Play-fighting differs from serious fighting in both target of attack and tactics of fighting in the laboratory rat Rattus norvegicus. Aggress Behav 13: 227-242.
56. Pellis SM, Pellis VC (1998). Play fighting of rats in comparative perspective: a schema for neurobehavioral analyses. Neurosci Biobehav Rev 23: 87-101.
57. Pietras CJ, Cherek DR, Lane SD, Tcheremissine OV, Steinberg JL (2003). Effects of methylphenidate on impulsive choice in adult humans. Psychopharmacology 170: 390-398.
58. Poole TB, Fish J (1975). An investigation of playful behavior in Rattus norvegicus and Mus musculus (Mammalia). J Zool Lond 175: 61-71.
59. Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, Mikkelsen EJ (1980). Dextroamphetamine: its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 37: 933-943.
60. Rapoport JL, Buchsbaum MS, Zahn TP, Weingartner H, Ludlow C, Mikkelsen EJ (1978). Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science 199: 560-563.
61. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223.
62. Robbins TW, Sahakian BJ (1979). 'Paradoxical' effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology 18: 931-950.
63. Robbins TW, Watson BA, Gaskin M, Ennis C (1983). Contrasting interactions of pipradol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement. Psychopharmacology 80: 113-119.
64. Robinson ESJ, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X et al (2007). Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology; doi: 10.1038/sj.npp.1301487.
65. Robinson TE, Becker JB (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11: 157-198.
66. Salamone JD, Correa M, Farrar A, Mingote SM (2007). Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191: 461-482.
67. Schachter HM, Pham B, King J, Langford S, Moher D (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 165: 1475-1488.
68. Schiørring E (1979). Social isolation and other behavioral changes in groups of adult vervet monkeys (Cercopithecus aethiops) produced by low, nonchronic doses of d-amphetamine. Psychopharmacology 64: 297-302.
69. Schultz W (2002). Getting formal with dopamine and reward. Neuron 36: 241-263.
70. Siviy SM (1998). Neurobiological substrates of play behavior: glimpses into the structure and function of mammalian playfulness. In: Bekoff M, Byers JA (eds). Animal Play. Cambridge University Press: Cambridge. pp 221-242.
71. Siviy SM, Fleischhauer AE, Kerrigan LA, Kuhlman SJ (1996). D2 dopamine receptor involvement in the rough-and-tumble play behavior of juvenile rats. Behav Neurosci 110: 1168-1176.
72. Siviy SM, Fleischhauer AE, Kuhlman SJ, Atrens DM (1994). Effects of alpha-2 adrenoceptor antagonists on rough-and-tumble play in juvenile rats: evidence for a site of action independent of non-adrenoceptor imidazoline binding sites. Psychopharmacology 113: 493-499.
73. Siviy SM, Panksepp J (1987). Sensory modulation of juvenile play in rats. Dev Psychobiol 20: 39-55.
74. Solanto MV (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94: 127-152.
75. Solanto MV (2000). Clinical psychopharmacology of AD/HD: implications for animal models. Neurosci Biobehav Rev 24: 27-30.
76. Solanto MV, Wender EH, Bartell SS (1997). Effects of methylphenidate and behavioral contingencies on sustained attention in attention-deficit hyperactivity disorder: a test of the reward dysfunction hypothesis. J Child Adolesc Psychopharmacol 7: 123-136.
77. Spencer T, Heiligenstein JH, Biederman J, Faries DE, Kratochvil CJ, Conners CK et al (2002). Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/ hyperactivity disorder. J Clin Psychiatry 63: 1140-1147.
78. Špinka M, Newberry RC, Bekoff M (2001). Mammalian play: training for the unexpected. Q Rev Biol 76: 141-168.
79. Sproson EJ, Chantrey J, Hollis C, Marsden CA, Fone KCF (2001). Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats. J Psychopharmacol 15: 67-75.
80. Starke K, Göthert M, Kilbinger H (1989). Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69: 864-898.
81. Stewart J, Badiani A (1993). Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4: 289-312.
82. Tannock R, Schachar RJ, Carr RP, Chajczyk D, Logan GD (1989). Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol 17: 473-491.
83. Thor DH, Holloway Jr WR (1983). Play soliciting in juvenile male rats: effects of caffeine, amphetamine and methylphenidate. Pharmacol Biochem Behav 19: 725-727.
84. Van den Berg CL, Hol T, Van Ree JM, Spruijt BM, Everts H, Koolhaas JM (1999a). Play is indispensable for an adequate development of coping with social challenges in the rat. Dev Psychobiol 34: 129-138.
85. Van den Berg CL, Pijlman FTA, Koning HAM, Diergaarde L, Van Ree JM, Spruijt BM (1999b). Isolation changes the incentive value of sucrose and social behaviour in juvenile and adult rats. Behav Brain Res 106: 133-142.
86. van Gaalen MM, van Koten RC, Schoffelmeer ANM, Vanderschuren LJMJ (2006). Critical involvement of dopaminergic neurotransmission in impulsive decision-making. Biol Psychiatry 60: 66-73.
87. Vanderschuren LJMJ, Kalivas PW (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151: 99-120.
88. Vanderschuren LJMJ, Niesink RJM, Spruijt BM, Van Ree JM (1995a). Effects of morphine on different aspects of social play in juvenile rats. Psychopharmacology 117: 225-231.
89. Vanderschuren LJMJ, Niesink RJM, Van Ree JM (1997). The neurobiology of social play behavior in rats. Neurosci Biobehav Rev 21: 309-326.
90. Vanderschuren LJMJ, Spruijt BM, Hol T, Niesink RJM, Van Ree JM (1995b). Sequential analysis of social play behavior in juvenile rats: effects of morphine. Behav Brain Res 72: 89-95.
91. Volkow ND, Wang G-J, Fowler JS, Telang F, Maynard L, Logan J et al (2004). Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 161: 1173-1180.
92. Wise RA (2004). Dopamine, learning and motivation. Nat Rev Neurosci 5: 483-494.
93. Wolterink G, Phillips G, Cador M, Donselaar-Wolterink I, Robbins TW, Everitt BJ (1993). Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement. Psychopharmacology 110: 355-364.
94. Wyvell CL, Berridge KC (2000). Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: enhancement of reward 'wanting' without enhanced 'liking' or response reinforcement. J Neurosci 20: 8122-8130.